# Haupt Pharma Latina Srl - Inspection Records

Source: https://www.keypedia.com/companies/haupt-pharma-latina-srl/0976ff44-458f-4749-a2d5-3d2728a17a6d

> Inspection records and compliance data for Haupt Pharma Latina Srl in Latina, None. Access full analysis and detailed observations.

---

## Details

- Name: Haupt Pharma Latina Srl
- FEI Number: 3007687501
- City: Latina
- State: None
- Country Name: Italy
- Address Line 1: Strada Statale 156 Dei Monti Lepini 47/600
- Zip Code: None
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1237210 - Haupt Pharma Latina Srl - 2024-02-21](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/da230bb7-6bc7-46a4-8eb7-d12e3b9bca48) — classification: Official Action Indicated (OAI), source: FDA, date: February 21, 2024
- [FDA Inspection 1206882 - Haupt Pharma Latina Srl - 2022-07-29](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/b6e783bc-eae7-4f74-ae33-5601dedd704e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 29, 2022
- [EIR - Haupt Pharma Latina Srl - 2018-08-27](https://www.keypedia.com/records/eir/haupt-pharma-latina-srl/ac50166b-5736-4924-b1e8-80ab23ff2a33) — source: FDA, date: August 27, 2018
- [EIR - Haupt Pharma Latina Srl - 2018-06-28](https://www.keypedia.com/records/eir/haupt-pharma-latina-srl/4187a6b8-4cb0-45a1-8926-b96b3588172d) — source: FDA, date: June 28, 2018
- [EIR - Haupt Pharma Latina Srl - 2018-06-28](https://www.keypedia.com/records/eir/haupt-pharma-latina-srl/f723b3a7-5690-4af6-b82d-eb30a17ebb4f) — source: FDA, date: June 28, 2018
- [FDA Inspection 1059418 - Haupt Pharma Latina Srl - 2018-06-28](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/5ef4acb7-982f-4bff-94ef-9475785820a7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2018
- [FDA Inspection 1059418 - Haupt Pharma Latina Srl - 2018-06-28](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/b1930b05-1ef6-4d34-9031-747b30c4454e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2018
- [FDA Inspection 1004993 - Haupt Pharma Latina Srl - 2016-12-16](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/a35287cd-3905-4eff-8542-e238ef9b726d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2016
- [FDA Inspection 1004993 - Haupt Pharma Latina Srl - 2016-12-16](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/f95ced13-1577-4476-a6f4-278856135a0a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2016
- [FDA Inspection 908678 - Haupt Pharma Latina Srl - 2014-11-04](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/d2b4ac28-e9d0-4e5b-b074-ecf87c96dcb3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 4, 2014
- [FDA Inspection 812047 - Haupt Pharma Latina Srl - 2012-12-12](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/e1abd4fd-1656-4d61-94d8-60acc5b7904b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 12, 2012
- [FDA Inspection 624989 - Haupt Pharma Latina Srl - 2009-10-13](https://www.keypedia.com/records/fda_inspections/haupt-pharma-latina-srl/700ab12b-5258-4bf5-9689-a24a13d932aa) — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2009

## Related Companies

- [AXXELENT PHARMA SCIENCE PRIVATE LIMITED](https://www.keypedia.com/companies/axxelent-pharma-science-private-limited/0e17ded9-51c9-4db9-9ceb-e39cb2d439db)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dbfac016-3c29-44aa-845b-d79000c4abd2)
- [Cerovene Inc.](https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08)
- [Kenvue Brands LLC](https://www.keypedia.com/companies/kenvue-brands-llc/2f06d979-d58e-4f22-9975-eba786e0bed7)
- [Strides Pharma, Inc.](https://www.keypedia.com/companies/strides-pharma-inc/e9e4da51-c260-486c-8969-86d64b9b36af)
- [Novel Laboratories, Inc. d.b.a Lupin Somerset](https://www.keypedia.com/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391)
- [CMIC CMO USA Corporation](https://www.keypedia.com/companies/cmic-cmo-usa-corporation/026de3c9-7077-4859-bf21-6304c0c50f29)
- [Strides Alathur Private Limited](https://www.keypedia.com/companies/strides-alathur-private-limited/9e386d26-e737-4541-bcac-29deef78649b)
- [HP Halden Pharma AS](https://www.keypedia.com/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728)
- [ARNA Pharma Pty., Ltd.](https://www.keypedia.com/companies/arna-pharma-pty-ltd/e06145c8-ecf7-4bc1-9e0d-5aab8615b08f)

## Related Officers

- [Investigator](https://www.keypedia.com/people/rachael-a-moliver/6130c1d8-9867-4da5-b113-1bbaf0ae9c79)
- [Investigator -Federal Program Manager](https://www.keypedia.com/people/chad-n-thompson/f99444f7-cffb-43d0-b102-315d12115b9e)